[Form 4] Synovus Financial Corp. Insider Trading Activity

Rhea-AI Filing Summary

Synovus Financial Corp. (SNV) Form 4: EVP & Chief Risk Officer Shellie Creson purchased 1,000 common shares on 08/05/2025 at $47.79 (code “P”). Following the open-market buy, Creson directly owns 27,258 shares. No derivative trades were reported.

The ~$48k purchase represents a modest vote of confidence from a senior executive but is financially immaterial relative to Synovus’s market capitalization and is unlikely to move the stock on its own.

Positive

• Insider purchase: Senior officer bought 1,000 shares, indicating personal confidence.

Negative

• Low dollar amount: ~$48k is insignificant versus Synovus’s market cap, limiting signal strength.

Insights

Equity Analyst

TL;DR: Minor insider buy; positive sentiment, negligible valuation impact.

An EVP buying 1,000 shares is directionally bullish, suggesting management’s confidence after recent market activity. However, at under $50k, the purchase equals a fraction of daily trading volume and does not materially alter insider ownership percentages. Investors may view it as a soft, longer-term signal rather than an actionable catalyst.

Corporate Governance Expert

TL;DR: Routine disclosure, no governance red flags detected.

The filing is timely, properly signed, and shows compliance with Section 16 reporting. No 10b5-1 plan was cited, indicating discretionary buying. The transaction aligns with sound governance practices but its small size limits informational value. Overall impact: neutral.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Creson Shellie

(Last) (First) (Middle)

P.O. BOX 120

(Street)

COLUMBUS GA 31902

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SYNOVUS FINANCIAL CORP [ SNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Chief Risk Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2025		P		1,000	A	$47.79	27,258	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mary Maurice Young	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many SNV shares did EVP Shellie Creson buy?

Creson purchased 1,000 common shares.

What price was paid for the Synovus shares?

The shares were bought at $47.79 each.

How many SNV shares does Creson now own?

After the transaction, Creson holds 27,258 direct shares.

Was the purchase made under a Rule 10b5-1 trading plan?

No. The Form 4 does not indicate use of a 10b5-1 plan.

Why is Form 4 important to investors?

Form 4 discloses insider transactions, offering insight into executives’ confidence and potential alignment with shareholders.